Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $421.07 | 28 | 93.4% |
| Education | $29.99 | 1 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $140.47 | 9 | $0 (2019) |
| Allergan, Inc. | $116.11 | 7 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $59.34 | 4 | $0 (2020) |
| Indivior Inc. | $31.47 | 2 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.07 | 2 | $0 (2019) |
| ABBVIE INC. | $23.64 | 1 | $0 (2022) |
| Eisai Inc. | $14.79 | 1 | $0 (2021) |
| Shire North American Group Inc | $14.33 | 1 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $13.74 | 1 | $0 (2019) |
| Lundbeck LLC | $12.10 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $23.64 | 1 | ABBVIE INC. ($23.64) |
| 2021 | $14.79 | 1 | Eisai Inc. ($14.79) |
| 2020 | $34.76 | 2 | Janssen Pharmaceuticals, Inc ($21.42) |
| 2019 | $248.49 | 17 | Otsuka America Pharmaceutical, Inc. ($86.74) |
| 2018 | $129.38 | 8 | Otsuka America Pharmaceutical, Inc. ($53.73) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.79 | General |
| Category: Neurology | ||||||
| 02/04/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA SUSTENNA, INVEGA TRINZA | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Neuroscience | ||||||
| 01/28/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2019 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug), INVEGA SUSTENNA, SPRAVATO | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Neuroscience | ||||||
| 09/04/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, SPRAVATO | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Neuroscience | ||||||
| 07/01/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: PSYCHIATRY | ||||||
| 06/12/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Central Nervous System | ||||||
| 05/20/2019 | Shire North American Group Inc | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: NEUROSCIENCE | ||||||
| 02/25/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: Neuroscience | ||||||
| 02/18/2019 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.10 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 02/06/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: NEUROSCIENCE | ||||||
| 01/15/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Central Nervous System (CNS) | ||||||
| 12/04/2018 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: OUD | ||||||
| 11/05/2018 | Indivior Inc. | SUBLOCADE (Drug), SUBOXONE SUBLINGUAL FILM | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: OUD | ||||||
| 10/29/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 143 | 467 | $87,068 | $27,349 |
| 2022 | 3 | 191 | 737 | $132,102 | $49,434 |
| 2021 | 3 | 249 | 873 | $157,000 | $63,853 |
| 2020 | 5 | 285 | 704 | $131,805 | $47,720 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 260 | $55,120 | $17,076 | 31.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 63 | 190 | $26,421 | $8,220 | 31.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 17 | 17 | $5,527 | $2,052 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 355 | $75,260 | $29,073 | 38.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 85 | 362 | $50,340 | $17,853 | 35.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 20 | 20 | $6,502 | $2,508 | 38.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 112 | 424 | $89,911 | $38,618 | 43.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 112 | 424 | $58,961 | $21,814 | 37.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 25 | 25 | $8,128 | $3,421 | 42.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 110 | 331 | $70,172 | $25,061 | 35.7% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 105 | 300 | $41,718 | $16,009 | 38.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 36 | 36 | $11,704 | $3,871 | 33.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 20 | $5,780 | $1,788 | 30.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 17 | $2,431 | $992.35 | 40.8% |
About Dr. Ramneesh Baweja, MD
Dr. Ramneesh Baweja, MD is a Psychiatry healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2012. The National Provider Identifier (NPI) number assigned to this provider is 1548525413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramneesh Baweja, MD has received a total of $451.06 in payments from pharmaceutical and medical device companies, with $23.64 received in 2022. These payments were reported across 29 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($421.07).
As a Medicare-enrolled provider, Baweja has provided services to 868 Medicare beneficiaries, totaling 2,781 services with total Medicare billing of $188,356. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Psychiatry
- Location Texarkana, TX
- Active Since 07/06/2012
- Last Updated 02/18/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548525413
Products in Payments
- VRAYLAR (Drug) $139.75
- REXULTI (Drug) $137.95
- SUBLOCADE (Drug) $31.47
- Trintellix (Drug) $25.07
- INVEGA SUSTENNA (Drug) $21.97
- SPRAVATO (Drug) $21.42
- INVEGA TRINZA (Drug) $15.95
- Dayvigo (Drug) $14.79
- ABILIFY MAINTENA (Drug) $14.62
- TRINTELLIX (Drug) $14.33
- AUSTEDO (Drug) $13.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Texarkana
Nancy Graves, M.d, M.D
Psychiatry — Payments: $11,051
Edward Tobey, Md, MD
Psychiatry — Payments: $6,813
Gregory Montoya, Md, MD
Psychiatry — Payments: $6,675
Dr. Donna Brister, D.o, D.O
Psychiatry — Payments: $4,726
Catherine Pearson, Aprn, APRN
Psychiatry — Payments: $16.86
Dr. Marianne Seidel, M.d, M.D
Psychiatry